NOW vs TMO: Which Is the Better Buy?
Side-by-side comparison of ServiceNow, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
ServiceNow, Inc. · Technology
$139.82
+16.2% upside to fair value
Med Conviction
Grade A-
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NOW |
TMO |
| Current Price |
$139.82 |
$658.32 |
| Fair Value Estimate |
$162.50 |
$863.34 |
| Upside to Fair Value |
+16.2%
|
+31.1%
|
| Market Cap |
$144.6B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
43.1x
|
25.9x
|
| Price / Sales |
9.8x
|
5.3x
|
| Price / FCF |
31.5x
|
33.4x
|
| Revenue Growth YoY |
+24.0%
|
+10.5%
|
| Gross Margin |
74.8%
|
40.4%
|
| Operating Margin |
11.4%
|
17.7%
|
| Return on Equity |
13.8%
|
13.4%
|
| Dividend Yield |
0% |
0.28% |
| FCF Yield |
3.17%
|
3.0%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
NOW |
TMO |
| Zone Low |
$121.88 |
$647.50 |
| Zone High |
$138.12 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|